Pasithea Therapeutics Corp. Common Stock
$0.49
-$0.01 (-2.00%)
$0.49Day Range$0.51
Key Statistics
Market Cap
$16.71M
Shares Outstanding
33.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 15, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$0.50
Day High
$0.51
Day Low
$0.49
Volume
80.8K
VWAP
$0.50
Prev Close
$0.50
Transactions
--
Acc. Volume
--
About Pasithea Therapeutics Corp. Common Stock
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
PHARMACEUTICAL PREPARATIONSSIC 28345 employees1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139(702) 514-4174IPO Sep 15, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001841330
- Composite FIGI
- BBG01018ZGY8
- Share Class FIGI
- BBG01018ZHS3
- Ticker Root
- KTTA
- SIC Code
- 2834
About Pasithea Therapeutics Corp. Common Stock (KTTA) Stock
Pasithea Therapeutics Corp. Common Stock (KTTA) closed the 2026-09-16 session at $0.49, down 2.00% versus the previous close (-0.01). The stock opened at $0.50 and traded between $0.49 and $0.51 during that session. Session trading volume was 81K shares. The volume-weighted average price (VWAP) is $0.50.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
Pasithea Therapeutics Corp. Common Stock has a market capitalization of $16.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. KTTA is listed on the XNAS exchange. The company employs approximately 5 people. Pasithea Therapeutics Corp. Common Stock is headquartered in MIAMI BEACH, FL. The recorded listing date is 2021-09-15.
On this page you can find market KTTA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.